Showing results (1-10 of 377) with videos related to
Sort By:
Pageof 38
Cancer Treatment Reviews|August 15, 2017
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysisElisa Roca, Cristina Gurizzan, Vito Amoroso, et al.Cancers|October 27, 2022
Endocrine and Neuroendocrine Tumors: A Special IssueAlfredo Berruti, Vito Amoroso, Nicola FazioClinical Genitourinary Cancer|February 19, 2018
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysisMélanie Claps, Fausto Petrelli, Orazio Caffo, et al.Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional caseElisa Roca, Marta Pozzari, William Vermi, et al.Oncology|July 24, 2018
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective StudyRebecca Pedersini, Lucia Vassalli, Melanie Claps, et al.Expert Opinion on Investigational Drugs|July 26, 2014
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumorsAndrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, et al.Tumori|November 10, 2025
Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancersLaura Deborah Locati, Federica Puce, Vito Amoroso, et al.Endocrine|June 4, 2020
Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of viewValeria Tovazzi, Vittorio D Ferrari, Alberto Dalla Volta, et al.Frontiers in Oncology|August 21, 2024
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case reportElena Fassi, Vito Amoroso, Deborah Cosentini, et al.Bone|January 21, 2017
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional studyRebecca Pedersini, Sara Monteverdi, Gherardo Mazziotti, et al.Pageof 38